日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Long-term follow-up of predominantly Asian patients with relapsed/refractory FLT3-mutated acute myeloid leukemia in the phase 3 COMMODORE trial

COMMODORE III期试验中，主要为亚洲复发/难治性FLT3突变急性髓系白血病患者的长期随访

期刊:Annals of Hematology
影响因子:2.4
doi:10.1007/s00277-026-06762-2
Jiang, Bin; Li, Jian; Liu, Ligen; Du, Xin; Jiang, Hao; Hu, Jianda; Zeng, Xiaoxi; Sakatani, Taishi; Kosako, Masanori; Deng, Yaru; Ivanov, Vladimir; Bondarenko, Sergey; Lee Lee, Lily Wong; Khuhapinant, Archrob; Martynova, Elena; Hasabou, Nahla; An, Jamie Jung-Hee; Wang, Jianxiang
白血病
FLT3
多发性骨髓瘤
发表日期：2026
文献求助 收藏

Nonionotropic action of an acid-sensing ion channel inhibits leukemogenesis in the acidic bone marrow niche

酸敏感离子通道的非离子型作用可抑制酸性骨髓微环境中的白血病发生。

期刊:Journal of Clinical Investigation
影响因子:13.6
doi:10.1172/JCI189051
Gu, Hao; Weng, Lietao; Chen, Chiqi; Hao, Xiaoxin; Tao, Rongkun; Qi, Xin; Lai, Xiaoyun; Liu, Ligen; Zhang, Tinghua; Jiang, Yiming; Wang, Jin; Li, Wei-Guang; Yu, Zhuo; Xie, Li; Zhang, Yaping; He, Xiaoxiao; Yu, Ye; Yang, Yi; Wu, Dehua; Zhao, Yuzheng; Xu, Tian-Le; Chen, Guo-Qiang; Zheng, Junke
白血病
发表日期：2025
文献求助 收藏

Noscapine derivative 428 suppresses ferroptosis through targeting GPX4.

诺斯卡品衍生物 428 通过靶向 GPX4 抑制铁死亡

期刊:Redox Biology
影响因子:11.9
doi:10.1016/j.redox.2025.103635
Zhang Youping, Shi Haoliang, Wang Yingying, Liu Wanting, Li Guanyi, Li Defeng, Wu Wenxuan, Wu Yunzhao, Zhang Ziwei, Ji Yanjie, Zhu Chujiao, Bai Wenhui, Lei Hu, Xu Hanzhang, Zhong Hua, Han Baohui, Yang Li, Liu Ligen, Wang Wei, Zhao Yaxue, Zhang Yongqiang, Wu Yingli
信号转导
铁死亡
发表日期：2025
文献求助 收藏

Novel CD19 Fast-CAR-T cells vs. CD19 conventional CAR-T cells for the treatment of relapsed/refractory CD19-positive B-cell acute lymphoblastic leukemia

新型 CD19 快速 CAR-T 细胞与 CD19 传统 CAR-T 细胞治疗复发/难治性 CD19 阳性 B 细胞急性淋巴细胞白血病的比较

期刊:Chinese Medical Journal
影响因子:7.3
doi:10.1097/CM9.0000000000003479
Tan, Xu; Wang, Jishi; Chen, Shangjun; Liu, Li; Li, Yuhua; Tu, Sanfang; Yi, Hai; Zhou, Jian; Wang, Sanbin; Liu, Ligen; Ge, Jian; Hu, Yongxian; Wang, Xiaoqi; Wang, Lu; Chen, Guo; Yao, Han; Zhang, Cheng; Zhang, Xi
白血病
细胞生物学
T细胞
CD19
发表日期：2025
文献求助 收藏

BCAT1 contributes to the development of TKI-resistant CML

BCAT1 参与了 TKI 耐药性 CML 的发展。

期刊:Cellular Oncology
影响因子:4.8
doi:10.1007/s13402-024-01003-y
Jiang, Yu; Zhang, Difan; He, Xiaoxiao; Chen, Chiqi; Xie, Li; Liu, Ligen; Yu, Zhuo; Zhang, Yaping; Zheng, Junke; Huang, Dan
BCAT1
发表日期：2025
文献求助 收藏

Risk-stratified treatment of sonrotoclax with chemotherapy in newly diagnosed acute myeloid leukemia: a study protocol

对新诊断的急性髓系白血病患者进行风险分层的索诺托克联合化疗治疗：一项研究方案

期刊:Future Oncology
影响因子:2.6
doi:10.1080/14796694.2025.2469487
Zhang, Yunxiang; Wu, Min; Jin, Zhen; Yang, Li; Huang, Xufei; Li, Weiming; Zhu, Hongming; Wang, Wenfang; Chen, Qiusheng; Liu, Ligen; Chen, Zhichao; Wang, Shaoyuan; Li, Junmin
白血病
发表日期：2025
文献求助 收藏

Gilteritinib versus salvage chemotherapy in predominantly Asian patients with relapsed/refractory FLT3-mutated acute myeloid leukemia: a regional analysis of COMMODORE in China, South-East Asia, and Russia

吉瑞替尼与挽救性化疗治疗复发/难治性FLT3突变急性髓系白血病（主要为亚洲患者）：COMMODORE研究在中国、东南亚和俄罗斯的区域分析

期刊:Annals of Hematology
影响因子:2.4
doi:10.1007/s00277-025-06235-y
Jiang, Bin; Li, Jian; Liu, Ligen; Du, Xin; Jiang, Hao; Hu, Jianda; Zeng, Xiaoxi; Sakatani, Taishi; Kosako, Masanori; Deng, Yaru; Girshova, Larisa; Bondarenko, Sergey; Lee, Lily Wong Lee; Khuhapinant, Archrob; Martynova, Elena; Hasabou, Nahla; Wang, Jianxiang
白血病
FLT3
多发性骨髓瘤
发表日期：2025
文献求助 收藏

Efficacy and safety analysis of China's first 10% IVIg (RonsenGlob) therapy in treating adult ITP

中国首个10%静脉注射免疫球蛋白（RonsenGlob）疗法治疗成人ITP的疗效和安全性分析

期刊:Annals of Hematology
影响因子:2.4
doi:10.1007/s00277-025-06391-1
Fang, Lijun; Sun, Ting; Zhou, Hu; Jie, Guitao; Fu, Jiaping; Yang, Enqin; Zhou, Zeping; Liu, Ligen; Zhang, Jingyu; Qian, Shenxian; Chen, Yun; Liu, Ling; Gu, Jian; Kong, Fanliang; Huang, Ruibin; Chen, Yunfei; Zhang, Lei
免疫/内分泌
发表日期：2025
文献求助 收藏

Identification of USP2 as a novel target to induce degradation of KRAS in myeloma cells.

鉴定出 USP2 是诱导骨髓瘤细胞中 KRAS 降解的新靶点

期刊:Acta Pharmaceutica Sinica B
影响因子:14.6
doi:10.1016/j.apsb.2024.08.019
Wang Yingying, Zhang Youping, Luo Hao, Wei Wei, Liu Wanting, Wang Weiwei, Wu Yunzhao, Peng Cheng, Ji Yanjie, Zhang Jianfang, Zhu Chujiao, Bai Wenhui, Xia Li, Lei Hu, Xu Hanzhang, Yin Leimiao, Weng Wei, Yang Li, Liu Ligen, Zhou Aiwu, Wei Yueyue, Zhu Qi, Zhu Weiliang, Yang Yongqing, Xu Zhijian, Wu Yingli
细胞生物学
骨髓瘤
发表日期：2024
文献求助 收藏

LILRB4 regulates multiple myeloma development through STAT3-PFKFB1 pathway

LILRB4 通过 STAT3-PFKFB1 通路调控多发性骨髓瘤的发生发展。

期刊:Cell Death & Disease
影响因子:9.6
doi:10.1038/s41419-024-06883-4
Xie, Li; Chen, Chiqi; Zhang, Tinghua; Yang, Wenqian; Zheng, Denghao; Cao, Liyuan; Yuan, Jin; Xu, Yilu; Zhang, Yaping; Liu, Ligen; Liang, Aibin; Yu, Zhuo; Zheng, Junke
多发性骨髓瘤
JAK/STAT
信号转导
STAT3
骨髓瘤
发表日期：2024
文献求助 收藏